Gros R, You X, Baggio LL, Kabir MG, Sadi AM, Mungrue IN, et al
The boxed warning about thyroid C-cell tumors applies to all GLP-1 drugs and prohibits their use in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
All programs require an Ivm Health membership, priced at $74.99/month
Managing keratosis pilaris in primary care involves a holistic approach focusing on patient education, consistent skincare, and appropriate use of topical treatments
In summary, the results of this analysis support that some individuals may experience changes to the menstrual cycle when taking GLP-1 medications for weight loss, specifically with periods becoming more predictable and frequent